Last $586.00 MXN
Change Today +1.21 / 0.21%
Volume 94.0
MRK* On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
EN Paris
As of 4:08 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter N. Kellogg

Chief Financial Officer and Executive Vice President, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 5 different industries.

See Board Relationships
55$5,745,323
As of Fiscal Year 2012

Background*

Mr. Peter N. Kellogg has been Chief Financial Officer and Executive Vice President at Merck & Co. Inc. since August 14, 2007. Mr. Kellogg served as an Executive Vice President of Finance and Chief Financial Officer of Biogen Idec Inc. since November 2003 and served as its Principal Accounting Officer until December 2006. Mr. Kellogg served as an Executive Vice President of Finance and Chief Financial Officer of Finance of Biogen Inc. (now Biogen Idec Ma Inc.) since October ...

Read Full Background

Corporate Headquarters*

One Merck Drive
Whitehouse Station, New Jersey 08889-0100

United States

Phone: 908-423-1000
Fax: 908-735-1253

Board Members Memberships*

Chief Financial Officer and Executive Vice President
2007-Present
Director and Member of Audit Committee

Education*

BS
Princeton University
BSE
Princeton University
MBA
University of Pennsylvania
MBA
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Salary$973,362
Total Annual Compensation$973,362

Stock Options*

Restricted Stock Awards$1,818,176
All Other Compensation$19,282
Exercisable Options550,658
Exercisable Options Value$3,029,138
Unexercisable Options463,236
Unexercisable Options Value$1,605,129
Total Value of Options$4,634,267
Total Number of Options1,013,894

Total Compensation*

Total Annual Cash Compensation$2,049,060
Total Short Term Compensation$973,362
Other Long Term Compensation$1,837,458
Total Calculated Compensation$5,745,323
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK*:MM $586.00 MXN +1.21

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€3.0M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
1.9M GBP
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.5M
Severin Schwan Chief Executive Officer and Director
Roche Holding AG
SFr.6.5M
Jean-Paul Agon Chairman, Chief Executive Officer and Chairman of Strategy & Sustainable Development Committee
L'Oreal SA
€3.9M
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.